Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 362

    1.

    Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.

    Linde C, Gold MR, Abraham WT, St John Sutton M, Ghio S, Cerkvenik J, Daubert C; on behalf of the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group.

    Eur Heart J. 2013 May 2. [Epub ahead of print]

    PMID:
    23641006
    [PubMed - as supplied by publisher]
    2.

    How Many Transvenous Coils are Optimal for Defibrillators: One, Two or None?

    Netzler PC, Gold MR.

    Heart Rhythm. 2013 Apr 24. doi:pii: S1547-5271(13)00444-X. 10.1016/j.hrthm.2013.04.022. [Epub ahead of print] No abstract available.

    PMID:
    23624160
    [PubMed - as supplied by publisher]
    3.

    Influence of Intracardiac Pressure on Spontaneous Ventricular Arrhythmias in Patients With Systolic Heart Failure: Insights From the REDUCEhf Trial.

    Reiter MJ, Stromberg KD, Whitman TA, Adamson PB, Benditt DG, Gold MR.

    Circ Arrhythm Electrophysiol. 2013 Apr 1;6(2):272-8. doi: 10.1161/CIRCEP.113.000223. Epub 2013 Mar 20.

    PMID:
    23515265
    [PubMed - in process]
    4.

    The effect of left ventricular electrical delay on AV optimization for cardiac resynchronization therapy.

    Gold MR, Yu Y, Singh JP, Stein KM, Birgersdotter-Green U, Meyer TE, Seth M, Ellenbogen KA.

    Heart Rhythm. 2013 Mar 14. doi:pii: S1547-5271(13)00239-7. 10.1016/j.hrthm.2013.03.009. [Epub ahead of print]

    PMID:
    23499621
    [PubMed - as supplied by publisher]
    5.

    The invasion inhibitor sarasinoside A1 reverses mesenchymal tumor transformation in an e-cadherin-independent manner.

    Austin P, Freeman SA, Gray CA, Gold MR, Vogl AW, Andersen RJ, Roberge M, Roskelley CD.

    Mol Cancer Res. 2013 May;11(5):530-40. doi: 10.1158/1541-7786.MCR-12-0385. Epub 2013 Feb 11.

    PMID:
    23399642
    [PubMed - in process]
    6.

    Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices.

    Rowley CP, Bernard ML, Brabham WW, Netzler PC, Sidney DS, Cuoco F, Sturdivant JL, Leman RB, Wharton JM, Gold MR.

    Am J Cardiol. 2013 Apr 15;111(8):1165-8. doi: 10.1016/j.amjcard.2012.12.046. Epub 2013 Jan 26.

    PMID:
    23360767
    [PubMed - in process]
    7.

    Ethnic differences in atrial fibrillation identified using implanted cardiac devices.

    Lau CP, Gbadebo TD, Connolly SJ, Van Gelder IC, Capucci A, Gold MR, Israel CW, Morillo CA, Siu CW, Abe H, Carlson M, Tse HF, Hohnloser SH, Healey JS; ASSERT investigators.

    J Cardiovasc Electrophysiol. 2013 Apr;24(4):381-7. doi: 10.1111/jce.12066. Epub 2013 Jan 28.

    PMID:
    23356818
    [PubMed - in process]
    8.

    Comparison of fixed tilt and tuned defibrillation waveforms: the PROMISE study.

    Gold MR, Val-Mejias J, Cuoco F, Siddiqui M.

    J Cardiovasc Electrophysiol. 2013 Mar;24(3):323-7. doi: 10.1111/jce.12041. Epub 2012 Dec 4.

    PMID:
    23210764
    [PubMed - in process]
    9.

    Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.

    Durand CA, Richer MJ, Brenker K, Graves M, Shanina I, Choi K, Horwitz MS, Puri KD, Gold MR.

    Autoimmunity. 2013 Feb;46(1):62-73. doi: 10.3109/08916934.2012.732130.

    PMID:
    23039284
    [PubMed - in process]
    10.

    Is defibrillation testing of ICDs necessary?

    Sturdivant JL, Gold MR.

    Nat Rev Cardiol. 2012 Nov;9(11):618-9. doi: 10.1038/nrcardio.2012.144. Epub 2012 Oct 2.

    PMID:
    23026864
    [PubMed - indexed for MEDLINE]
    11.

    Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study.

    Mathew J, Katz R, St John Sutton M, Dixit S, Gerstenfeld EP, Ghio S, Gold MR, Linde C, Shlipak MG, Deo R.

    Eur J Heart Fail. 2012 Dec;14(12):1420-8. doi: 10.1093/eurjhf/hfs135. Epub 2012 Sep 6.

    PMID:
    22956574
    [PubMed - in process]
    12.
    13.

    The subcutaneous defibrillator.

    Rowley CP, Lobodzinski SS, Gold MR.

    Curr Treat Options Cardiovasc Med. 2012 Oct;14(5):550-7. doi: 10.1007/s11936-012-0196-3.

    PMID:
    22836713
    [PubMed]
    14.

    Atrial support pacing in heart failure: results from the multicenter PEGASUS CRT trial.

    Martin DO, Day JD, Lai PY, Murphy AL, Nayak HM, Villareal RP, Weiner S, Kraus SM, Stolen KQ, Gold MR.

    J Cardiovasc Electrophysiol. 2012 Dec;23(12):1317-25. doi: 10.1111/j.1540-8167.2012.02402.x. Epub 2012 Jul 25.

    PMID:
    22830441
    [PubMed - in process]
    15.

    Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.

    Gold MR, Thébault C, Linde C, Abraham WT, Gerritse B, Ghio S, St John Sutton M, Daubert JC.

    Circulation. 2012 Aug 14;126(7):822-9. doi: 10.1161/CIRCULATIONAHA.112.097709. Epub 2012 Jul 10.

    PMID:
    22781424
    [PubMed - indexed for MEDLINE]
    16.

    Subcutaneous implantable cardioverter defibrillator.

    Rowley CP, Gold MR.

    Circ Arrhythm Electrophysiol. 2012 Jun 1;5(3):587-93. doi: 10.1161/CIRCEP.111.964676. Review. No abstract available.

    PMID:
    22715237
    [PubMed - indexed for MEDLINE]
    17.

    Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF.

    Hauptman PJ, Schwartz PJ, Gold MR, Borggrefe M, Van Veldhuisen DJ, Starling RC, Mann DL.

    Am Heart J. 2012 Jun;163(6):954-962.e1. doi: 10.1016/j.ahj.2012.03.021.

    PMID:
    22709747
    [PubMed - indexed for MEDLINE]
    18.

    Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERT.

    Hohnloser SH, Healey JS, Gold MR, Israel CW, Yang S, van Gelder I, Capucci A, Lau CP, Fain E, Morillo CA, Ha A, Carlson M, Connolly SJ; ASSERT Investigators.

    Heart Rhythm. 2012 Oct;9(10):1667-73. doi: 10.1016/j.hrthm.2012.06.012. Epub 2012 Jun 12.

    PMID:
    22698765
    [PubMed - in process]
    19.

    The impact of different modalities for activating patients in a community health center setting.

    Deen D, Lu WH, Weintraub MR, Maranda MJ, Elshafey S, Gold MR.

    Patient Educ Couns. 2012 Oct;89(1):178-83. doi: 10.1016/j.pec.2012.04.012. Epub 2012 Jun 9.

    PMID:
    22683294
    [PubMed - indexed for MEDLINE]
    20.

    Relevance of electrical remodeling in human atrial fibrillation: results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial mechanisms of atrial fibrillation study.

    Healey JS, Israel CW, Connolly SJ, Hohnloser SH, Nair GM, Divakaramenon S, Capucci A, Van Gelder IC, Lau CP, Gold MR, Carlson M, Themeles E, Morillo CA.

    Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):626-31. doi: 10.1161/CIRCEP.112.970442. Epub 2012 Jun 5.

    PMID:
    22670051
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk